Rigel Launches VEPPANU for ESR1-Mutated Breast Cancer
South San Francisco, California, August 13, 2026 Rigel Pharmaceuticals, Inc. announced the U.S. commercial availability of VEPPANU™ (vepdegestrant) for...
fda approval
Advertisement
Novo Nordisk Launches Once-Weekly Awiqli in the U.S.
Plainsboro, New Jersey, August,11, 2026 Novo Nordisk has announced the nationwide U.S. launch of Awiqli® (insulin icodec-abae) injection 700...
Labcorp Wins FDA Approval for Melanoma Companion Diagnostic
Burlington, North Carolina, USA, August 10, 2026 Labcorp has announced that the U.S. Food and Drug Administration (FDA) has...
Replimune Wins FDA Approval for TUDRIQEV in Melanoma
Woburn, Massachusetts, USA, August 8, 2026 Replimune Group, Inc. has achieved a significant regulatory milestone with the U.S. Food...
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine
CAMBRIDGE, Mass., Aug. 5, 2026 Moderna, Inc. has received U.S. Food and Drug Administration (FDA) approval for mFLUSIVA® (mRNA-1010),...
Advertisements
Natera Submits Signatera to Japan PMDA for MIBC Approval
AUSTIN, Texas, August 5, 2026 Natera, Inc. has submitted an application to Japan’s Pharmaceuticals and Medical Devices Agency (PMDA)...
Zydus Secures USFDA Approval for Indocyanine Green
Ahmedabad, India / Pennington, New Jersey, August 4, 2026 Zydus Lifesciences Limited has received final approval from the U.S....
Dr. Reddy’s Expands Access to Immunotherapy for Rare Head and Neck Cancer
JOHANNESBURG, South Africa / HYDERABAD, India, Aug. 3, 2026 Dr. Reddy’s Laboratories South Africa announced the registration of an...
Dr. Reddy’s Laboratories Secures U.S. FDA Approval for Rituximab Biosimilar
HYDERABAD, India, Aug. 1, 2026 Dr. Reddy’s Laboratories Ltd. announced that the U.S. Food and Drug Administration (FDA) has...
Novartis’ Pluvicto Wins FDA Approval for Earlier Prostate Cancer Treatment
SILVER SPRING, Md., July 31, 2026 The U.S. Food and Drug Administration (FDA) has approved Novartis’ Pluvicto (lutetium Lu...
Advertisement
